ÂÜÀòÂÒÂ×

Dr. Guizhong Liu, Head of biology and pharmacology in Adagene, leading the preclinical pharmacology and toxicology research for product development. Dr. Liu has over 15-year experience in drug discovery and development, both in small molecule kinase inhibitors and large molecule antibodies in oncology and immunology field. Prior to joining Adagene, Dr. Liu served as head of molecular cancer biology in CrownBio, where he was in charge of contracted research projects from various big pharma and small biotech companies, as well as leading the novel drug development programs from biology and pharmacology side. Prior to CrownBio, Dr. Liu had worked as Assistant Professor in the department of oncological sciences at Mount Sinai School of Medicine, with over 40 peer-reviewed publications in high-profile journals. Dr. Liu completed his postdoctoral research with Dr. Stuart Aaronson at Mount Sinai School of Medicine, received his Ph.D. from Peking Union Medical College, and obtained his B.S. and M.S. degrees at Beijing Normal University.